Efficacy and safety of risk-stratified chemotherapy with azacitidine for children with myeloid leukaemia with Down syndrome: protocol for a multicentre phase II trial (JCCG AML-D24). [PDF]
Nakashima K +23 more
europepmc +1 more source
Efficacy of Nivolumab in Chemotherapy-Resistant Mesothelioma of the Tunica Vaginalis Testis: A Case Report. [PDF]
Koyanagi H +17 more
europepmc +1 more source
A randomized controlled trial of telemedicine and e-health interventions for the management of oral complications in oncology patients undergoing antineoplastic therapy. [PDF]
Petropoulou P +4 more
europepmc +1 more source
Evaluating Acupuncture for Chemotherapy-Induced Peripheral Neuropathic Pain: A Narrative Review of Clinical Evidence and Mechanistic Perspectives. [PDF]
Sousa P +7 more
europepmc +1 more source
Prophylactic strategies to reduce cyclophosphamide-induced sterile hemorrhagic cystitis in dogs: a first-opinion practice retrospective study and a referral survey. [PDF]
Ivanovs A +6 more
europepmc +1 more source
Durable complete metabolic response to enfortumab vedotin plus pembrolizumab in metastatic upper tract urothelial carcinoma: a case report. [PDF]
Tekin MD +5 more
europepmc +1 more source
An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C-IV non-squamous NSCLC. [PDF]
Li S +7 more
europepmc +1 more source
Pharmaceutical Compounding as a Pillar of Personalized Oncology: Current Applications, Emerging Technologies, and Future Perspectives. [PDF]
Mascarenhas-Melo F +4 more
europepmc +1 more source
HPV18-Positive Cervical Large Cell Neuroendocrine Carcinoma With Rapid Progression Despite Pembrolizumab Combined With Chemotherapy: A Case Report With Immunogenomic Insights. [PDF]
Ogura J +5 more
europepmc +1 more source
Outcomes of adolescents and young adults with AML treated on pediatric vs adult protocols. [PDF]
Krayem B +14 more
europepmc +1 more source

